A detailed history of Clark Capital Management Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Clark Capital Management Group, Inc. holds 3,729 shares of ABBV stock, worth $671,220. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,729
Previous 8,170 54.36%
Holding current value
$671,220
Previous $1.4 Million 47.47%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $727,613 - $885,224
-4,441 Reduced 54.36%
3,729 $736,000
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $505,079 - $589,819
3,263 Added 66.5%
8,170 $1.4 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $101,805 - $115,997
-637 Reduced 11.49%
4,907 $893,000
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $735,472 - $828,314
-5,345 Reduced 49.09%
5,544 $859,000
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $26,317 - $30,466
197 Added 1.84%
10,889 $1.62 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $109,320 - $136,042
-825 Reduced 7.16%
10,692 $1.44 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $40.5 Million - $46.7 Million
-280,334 Reduced 96.05%
11,517 $1.84 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $1.42 Million - $1.7 Million
10,257 Added 3.64%
291,851 $47.2 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $1.46 Million - $1.68 Million
10,897 Added 4.03%
281,594 $37.8 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $15 Million - $19.1 Million
-108,981 Reduced 28.7%
270,697 $41.5 Million
Q1 2022

May 16, 2022

BUY
$131.98 - $163.75 $1.29 Million - $1.6 Million
9,742 Added 2.63%
379,678 $61.6 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $612,888 - $775,480
5,705 Added 1.57%
369,936 $50.1 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $12.8 Million - $14.5 Million
120,309 Added 49.32%
364,231 $39.3 Million
Q2 2021

Aug 02, 2021

BUY
$105.21 - $117.21 $23.9 Million - $26.6 Million
227,236 Added 1361.84%
243,922 $27.5 Million
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $285,417 - $314,209
-2,790 Reduced 14.33%
16,686 $1.81 Million
Q4 2020

Jan 26, 2021

SELL
$80.49 - $108.67 $340,553 - $459,782
-4,231 Reduced 17.85%
19,476 $2.09 Million
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $7,989 - $9,377
93 Added 0.39%
23,707 $2.08 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $83,421 - $111,630
1,137 Added 5.06%
23,614 $2.32 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $137,449 - $208,390
-2,131 Reduced 8.66%
22,477 $1.71 Million
Q4 2019

Jan 27, 2020

BUY
$72.13 - $90.25 $22,504 - $28,158
312 Added 1.28%
24,608 $2.18 Million
Q3 2019

Nov 06, 2019

SELL
$62.98 - $75.72 $218,099 - $262,218
-3,463 Reduced 12.48%
24,296 $1.84 Million
Q2 2019

Jul 12, 2019

SELL
$65.7 - $83.98 $19,184 - $24,522
-292 Reduced 1.04%
27,759 $2.02 Million
Q1 2019

May 08, 2019

SELL
$77.14 - $90.79 $35.1 Million - $41.3 Million
-454,415 Reduced 94.19%
28,051 $2.26 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $75,125 - $92,649
-965 Reduced 0.2%
482,466 $44.5 Million
Q3 2018

May 08, 2019

SELL
$88.91 - $98.84 $15,648 - $17,395
-176 Reduced 0.04%
483,431 $45.7 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $5.64 Million - $6.27 Million
-63,417 Reduced 11.59%
483,607 $45.7 Million
Q2 2018

May 08, 2019

SELL
$89.78 - $106.23 $1,436 - $1,699
-16 Reduced -0.0%
547,024 $50.7 Million
Q2 2018

Aug 14, 2018

BUY
$89.78 - $106.23 $22.2 Million - $26.3 Million
247,403 Added 82.57%
547,040 $50.7 Million
Q1 2018

May 08, 2019

SELL
$92.01 - $123.21 $21,530 - $28,831
-234 Reduced 0.08%
299,637 $28.4 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $26.4 Million - $35.4 Million
-286,984 Reduced 48.9%
299,871 $28.4 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $8,329 - $9,133
93 Added 0.02%
586,855 $56.8 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $41 Million - $52.4 Million
586,762
586,762 $52.1 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Clark Capital Management Group, Inc. Portfolio

Follow Clark Capital Management Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clark Capital Management Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Clark Capital Management Group, Inc. with notifications on news.